![Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-06752-1/MediaObjects/12885_2020_6752_Fig5_HTML.png)
Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text
![Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-06752-1/MediaObjects/12885_2020_6752_Fig6_HTML.png)
Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text
![Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-06752-1/MediaObjects/12885_2020_6752_Fig2_HTML.png)
Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text
![L-Canavanine potentiates the cytotoxicity of doxorubicin and cisplatin in arginine deprived human cancer cells [PeerJ] L-Canavanine potentiates the cytotoxicity of doxorubicin and cisplatin in arginine deprived human cancer cells [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2016/1542/1/fig-2-2x.jpg)
L-Canavanine potentiates the cytotoxicity of doxorubicin and cisplatin in arginine deprived human cancer cells [PeerJ]
![Identification of synergistic drug combinations using breast cancer patient-derived xenografts | Scientific Reports Identification of synergistic drug combinations using breast cancer patient-derived xenografts | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-58438-0/MediaObjects/41598_2020_58438_Fig1_HTML.png)
Identification of synergistic drug combinations using breast cancer patient-derived xenografts | Scientific Reports
Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations
Antibiotics can be used to contain drug-resistant bacteria by maintaining sufficiently large sensitive populations
![The implications of target saturation for the use of drug–target residence time | Nature Reviews Drug Discovery The implications of target saturation for the use of drug–target residence time | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd.2018.234/MediaObjects/41573_2019_Article_BFnrd2018234_Fig1_HTML.jpg)
The implications of target saturation for the use of drug–target residence time | Nature Reviews Drug Discovery
Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma | Haematologica
Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations
![Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-06752-1/MediaObjects/12885_2020_6752_Fig4_HTML.png)